Qube Research & Technologies (QRT)
DSGN icon

Qube Research & Technologies (QRT)’s Design Therapeutics DSGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$364K Buy
+34,183
New +$346K ﹤0.01% 2828
2024
Q3 		– Sell
-2,986
Closed -$10K – 3491
2024
Q2 		$10K Buy
+2,986
New +$11.6K ﹤0.01% 2962
2022
Q2 		– Sell
-20,396
Closed -$329K – 2630
2022
Q1 		$329K Sell
20,396
-2,656
-12% -$40.7K ﹤0.01% 1736
2021
Q4 		$494K Buy
+23,052
New +$396K ﹤0.01% 1574

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Qube Research & Technologies (QRT)'s DSGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Design Therapeutics (DSGN) in Q1 2026: 34,183 shares worth $364K. The stake represents ﹤0.01% of the portfolio and ranks #2828 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in DSGN as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in DSGN in Q4 2021 and has held it in 4 quarters since. The position peaked at $494K in Q4 2021. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Qube Research & Technologies (QRT) held 34,183 shares of Design Therapeutics worth $364K as of Q1 2026.
  • Design Therapeutics was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Design Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2828 holding.
  • Qube Research & Technologies (QRT) first reported a position in Design Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • Qube Research & Technologies (QRT)'s Design Therapeutics position peaked at $494K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.